Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis.
Saved in:
| Title: | Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis. |
|---|---|
| Authors: | Oliver D; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Health Biomedical Research Centre, Oxford, United Kingdom.; OPEN Early Detection Service, Oxford Health NHS Foundation Trust, Oxford, United Kingdom.; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.; Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom., Chesney E; Department of Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Wallman P; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom., Estradé A; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom., Azis M; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom., Provenzani U; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy., Damiani S; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy., Melillo A; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.; Department of Physical and Mental Health and Preventive Medicine, University of Campania 'L. Vanvitelli', Naples, Italy., Hunt O; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom., Agarwala S; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom., Minichino A; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Health Biomedical Research Centre, Oxford, United Kingdom.; OPEN Early Detection Service, Oxford Health NHS Foundation Trust, Oxford, United Kingdom., Uhlhaas PJ; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany., McGuire P; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Health Biomedical Research Centre, Oxford, United Kingdom.; OPEN Early Detection Service, Oxford Health NHS Foundation Trust, Oxford, United Kingdom., Fusar-Poli P; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.; South London and the Maudsley National Health Service Foundation Trust, London, United Kingdom. |
| Source: | Frontiers in psychiatry [Front Psychiatry] 2026 Apr 27; Vol. 17, pp. 1823912. Date of Electronic Publication: 2026 Apr 27 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-0640 |
|---|---|
| DOI: | 10.3389/fpsyt.2026.1823912 |
